AI assistant
CONSTELLATION TECHNOLOGIES LIMITED — Director's Dealing 2011
Jun 30, 2011
64712_rns_2011-06-30_64864c53-ebaa-4e1c-b14f-a72ff98e2ab6.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
| Name of entity | Agenix Limited | Name of entity |
|---|---|---|
| ABN | 58 009 213 754 | ABN |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| We (the entity) give ASX the followingthe director for the purposes of section | information under listing rule 3.19A.2 and as agent for205G of the Corporations Act. | |
|---|---|---|
| Name of Director | Anthony Lee | |
| Date of last notice | 7 December 2010 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Direct |
|---|---|
| Nature of indirect interest | |
| (including registered holder) | |
| Note: Provide details of the circumstances giving rise to the relevant | |
| interest. | |
| Date of change | 30 June 2011 |
| No. of securities held prior to change | 4,695,279 ordinary shares |
| 64,056 listed options exercisable at $0.06 | |
| expiring 30 June 2012 | |
| 291,666 listed options exercisable at $0.30c | |
| expiring 30 June 2011. | |
| Class | Listed Options |
| Number acquired | Nil |
| Number disposed | Lapse of 291,666 listed options exercisable at |
| $0.30c expiring 30 June 2011. | |
| Value/Consideration | Nil |
| Note: If consideration is non‐cash, provide details and estimated | |
| valuation |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| No. of securities held after change | Direct4,695,279 ordinary shares64,056 listed options exercisable at $0.06expiring 30 June 2012. |
|---|---|
| Nature of changeExample: on‐market trade, off‐market trade, exercise of options,issue of securities under dividend reinvestment plan, participation inbuy‐back | Lapse of Options expiring 30 June 2011. |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| – Change of director’s interests in contractsthe case of a company, interests which come within paragraph (ii) of the definition of “notifiable intesed in this part. | rest of a director” should | ||
| Detai | l of contract | n/a | |
| Nature of interest | n/a | ||
| Name of registered holder(if issued securities) | n/a | ||
| Date of change | n/a | ||
| No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed | n/a | ||
| Interest acquired | n/a | ||
| Interest disposed | n/a | ||
| Value/ConsiderationNote: If consideration is non‐cash, provide detailsand an estimated valuation | n/a | ||
| Interest after change | n/a | ||
Part 3 –[+] Closed period
Were the interests in the securities or contracts detailed n/a above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade n/a to proceed during this period?
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
| If prior written clearance was provided, on what date was thisprovided? | n/a |
|---|---|
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3